| CAS No. | 496971-05-2 |
| Molecular Formula | C19H13N5OS |
| Molecular Weight | 359.40 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
CATO supplies 7-(1H-Benzo[d]imidazol-2-yl)-6-(phenylamino)thieno[3,2-d]pyrimidin-4(3H)-one (CAS 496971-05-2), a certified reference material (molecular formula C19H13N5OS, MW 359.40 g/mol) for analytical method development and quality control.
The molecular framework of 7-(1H-Benzo[d]imidazol-2-yl)-6-(phenylamino)thieno[3,2-d]pyrimidin-4(3H)-one (C19H13N5OS) is characterized by a steroid core, an amide group, sulfur-containing functionality, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
CATO manufactures 7-(1H-Benzo[d]imidazol-2-yl)-6-(phenylamino)thieno[3,2-d]pyrimidin-4(3H)-one under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Molecular Formula | C19H13N5OS |
| Molecular Weight | 359.40 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 16.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2025 |
| Nitrogen Atoms | 5 |
| Sulfur Atoms | 1 |